C L I N I C A L chem istry RE AG ENTS
www.sekisuidiagnostics.com
CO2
measurements
are used as
an aid in the
diagnosis and
treatment of
an acid-base
imbalance.
METHOD: ENZYMATIC (PHOSPHOENOLPYRUVATE CARBOXYLASE); RATE
features:
FOR THE QUANTITATIVE MEASUREMENT OF CARBON DIOXIDE
4 One part stable liquid reagent,
5X concentrate
Carbon Dioxide
(CO2) L3K® - C
4 Applicable to multiple
chemistry platforms
4 Serum and plasma are
acceptable sample types
Sekisui’s Carbon Dioxide (CO2) L3K® - Concentrate
Reagent uses an enzymatic procedure which is
easy to use and applicable to routine laboratory
instrumentation. It is intended for the measurement
of carbon dioxide in serum and plasma.
benefits:
4 Accommodates most testing
requirements regardless of
laboratory size or workload
4 Laboratory flexibility
4 Flexible sample types to meet
different laboratory needs
o rdering inf o r m at i o n C on f i g u r at ion cata log n u m ber
C A R B O N D I O X I DE ( C o2 ) L 3 K ® - C
R1 3 X 60 mL 288-36
C A RB O N D I O X I DE ( Co 2 ) L 3 K ® - C
R1 1 X 1000 mL 288-80
D C - C A L C A L I BR AT OR
5 X 3 mL SE -035
D C -TR O L LEV E L 1
10 X 5 mL SM -052
D C - TRO L LEV E L 2
10 X 5 mL SM -056
C 0 2 STA N D AR D *
1 X 15 mL DIAGNOSTI C S
The Americas
international
Sekisui Diagnostics, LLC
4 Hartwell Place
Lexington, MA 02421
Phone: 800 332 1042
Fax: 800 762 6311
Email: [email protected]
Sekisui Diagnostics (UK) Limited
50 Gibson Drive
Kings Hill, West Malling, Kent, ME19 4AF, UK
Phone: +44 (0) 1732 220022
Fax: +44 (0) 1732 220024
Email: [email protected]
©2013 Sekisui Diagnostics, LLC – All rights reserved.
9217
*Not available in Canada and Europe
80-7457-00-02 03/13
C L I N I C A L chem istry RE AG ENTS Carbon Dioxide L3K®- C
www.sekisuidiagnostics.com
Perf orman ce C h a r ac t e r i s t ics Pre cis ion
Within-Run: <1.3% (serum)
Within-Run: <1.9% (plasma)
Total Precision: <4.6%
Accur ac y
SERUM
Slope: 1.014
Intercept: 0.50 mmol/L (0.50 mEq/L)
Correlation Coefficient: 0.9944
PLASMA
Slope: 0.973
The performance of this method (y) was compared with the performance
Intercept: 0.89 mmol/L (0.89 mEq/L)
of another carbon dioxide method (x) on a Hitachi 717 analyzer.
Correlation Coefficient: 0.9907
®
Line a r i t y 1.0 - 50.0 mmol/L (1.0 - 50.0 mEq/L)
N o s igni f ican t int e r f e r ence s
up to l e ve l s indicat e d
Hemoglobin: 1000 mg/dL (155 μmol/L)
Ascorbic Acid: 3000 μg/dL (170 μmol/L)
Bilirubin: 40 mg/dL (684 μmol/L)
Intralipid: 1000 mg/dL (3000 mg/dL
[34 mmol/L] Simulated Triglycerides)
Ref e r enc e rang e (1) 22 - 29 mmol/L (22 - 29 mEq/L)
(1) Burtis, C.A., Ashwood, E.R.T., (Editors), Tietz Textbook of Clinical Chemistry, 3rd Edition, W.B. Saunders Company, Philadelphia (1999).
NOTES:
DIAGNOSTI C S
The Americas
international
Sekisui Diagnostics, LLC
4 Hartwell Place
Lexington, MA 02421
Phone: 800 332 1042
Fax: 800 762 6311
Email: [email protected]
Sekisui Diagnostics (UK) Limited
50 Gibson Drive
Kings Hill, West Malling, Kent, ME19 4AF, UK
Phone: +44 (0) 1732 220022
Fax: +44 (0) 1732 220024
Email: [email protected]
©2013 Sekisui Diagnostics, LLC – All rights reserved.